TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Cell Therapeutics, Inc. (NASDAQ:CTIC) Faces Yet Another Investor Investigation Over Possible New Securities Laws Violations

  • If you purchased shares of Cell Therapeutics, Inc. (NASDAQ:CTIC) in 2011 or 2012, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

San Diego, Feb. 14, 2012 (Shareholders Foundation) -- An new investigation on behalf of investors in shares of Cell Therapeutics, Inc. (NASDAQ:CTIC) was announced over new potential securities laws violations by certain officers and directors at Cell Therapeutics in connection with its statements in regards to its New Drug Application for Pixuvri(TM). The new investigation by a law f...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: